Tracking tumor DNA changes in advanced thyroid cancers
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at a small blood test (called ctDNA) and tumor tissue to understand how advanced thyroid cancers change over time. It may help doctors better monitor cancer growth and guide treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have one of these thyroid cancers: radioiodine-refractory differentiated thyroid cancer, medullary thyroid cancer, or anaplastic thyroid cancer
- You will be able to provide tumor material: either old stored biopsy tissue or you’re willing to have a new biopsy of an accessible spot
- You can follow the usual care plan and visit schedule your cancer team recommends
- You can sign consent for collecting blood and tissue samples; you are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects real-world information from patients with advanced thyroid cancer to better understand how standard treatments and specialized procedures work. Your participation will help improve care for others with this type of cancer.
This study looks at blood and urine samples from people newly diagnosed with papillary thyroid cancer or suspected follicular thyroid tumors. The goal is to find biomarkers that help predict risk and monitor the disease after treatment.
This trial tests a new way to choose chemotherapy for thyroid cancer by growing a 'mini-tumor' (organoid) from your biopsy and testing different drugs on it. The goal is to find the drug that is most likely to shrink your cancer.
This study is a registry that collects information about adults with certain types of thyroid cancer. It may help researchers learn more about these cancers and how people are doing over time.
This study is looking at how certain substances in the blood (called biomarkers) can help doctors understand and treat advanced thyroid cancer. It is for people who are about to start their first systemic therapy (medication that works throughout the body) for advanced thyroid cancer, and who have already had a genetic test on their tumor.
This trial takes a sample of your tumor during a standard procedure to grow it in a lab and test different drugs. The goal is to find which drugs might work best for people with your specific tumor DNA change.
Hear when a new Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.